| Stephen A Vile, MD | |
|
940 Lee St, Des Plaines, IL 60016-6555 | |
| (847) 299-5501 | |
| Not Available |
| Full Name | Stephen A Vile |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 58 Years |
| Location | 940 Lee St, Des Plaines, Illinois |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1275601163 | NPI | - | NPPES |
| 207W00000X | Other | IL | TAXOTOMY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | 3641556 (Illinois) | Primary |
| Entity Name | Stephen A Vile Md Sc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003099870 PECOS PAC ID: 9739178948 Enrollment ID: O20040929000323 |
News Archive
"Gathered at the Ford Foundation in New York Monday, international luminaries, family planning experts and women's rights activists ... marked the launch of a new 26-member high-level task force to galvanize support behind the goals of the International Conference on Population and Development (ICPD)," Inter Press Service reports.
IQ Therapeutics has completed the dosing of antibody IQNLF in a Phase I clinical trial. A total of 36 healthy volunteers participated in the randomized, placebo controlled, double blind, single dose-escalating study, intended to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of IQNLF.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
MedaSorb Technologies Corporation and its wholly-owned subsidiary CytoSorbents, Inc., announced that it has raised $1.3 million in the exercise of the warrant attached to the Series B financing completed in August 2008. Dr. Phillip Chan, Chief Executive Officer, stated, "We are pleased to have the continued support of our existing investors.
A unique curved barrier has been designed by researchers at Imperial College London, who publish new findings in the peer-reviewed journal Cities & Health on how the structure can protect people from the damaging effects of air pollution.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Stephen A Vile, MD 940 Lee St, Des Plaines, IL 60016-6555 Ph: (847) 299-5501 | Stephen A Vile, MD 940 Lee St, Des Plaines, IL 60016-6555 Ph: (847) 299-5501 |
News Archive
"Gathered at the Ford Foundation in New York Monday, international luminaries, family planning experts and women's rights activists ... marked the launch of a new 26-member high-level task force to galvanize support behind the goals of the International Conference on Population and Development (ICPD)," Inter Press Service reports.
IQ Therapeutics has completed the dosing of antibody IQNLF in a Phase I clinical trial. A total of 36 healthy volunteers participated in the randomized, placebo controlled, double blind, single dose-escalating study, intended to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of IQNLF.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
MedaSorb Technologies Corporation and its wholly-owned subsidiary CytoSorbents, Inc., announced that it has raised $1.3 million in the exercise of the warrant attached to the Series B financing completed in August 2008. Dr. Phillip Chan, Chief Executive Officer, stated, "We are pleased to have the continued support of our existing investors.
A unique curved barrier has been designed by researchers at Imperial College London, who publish new findings in the peer-reviewed journal Cities & Health on how the structure can protect people from the damaging effects of air pollution.
› Verified 7 days ago
Dr. Marshall Hirshman, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 8901 Golf Rd Ste 300, Suite 300, Des Plaines, IL 60016 Phone: 847-824-3127 Fax: 847-824-3346 | |
Dr. Robert Garoon, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 9301 Golf Rd, Des Plaines, IL 60016 Phone: 847-294-0080 | |
Dr. Daniel C Alter, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 8901 W. Golf Rd, 206, Des Plaines, IL 60016 Phone: 847-699-0006 Fax: 847-699-1744 | |
Kathryn Winkler, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 940 Lee St, Des Plaines, IL 60016 Phone: 847-299-5501 | |
Dr. Stephen Winkler, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 940 Lee St, Des Plaines, IL 60016 Phone: 847-299-5501 Fax: 410-601-6279 | |
Michael J. Shapiro, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2454 E Dempster St, Suite 400, Des Plaines, IL 60016 Phone: 847-299-0700 Fax: 847-390-0616 |